Conservative therapy of benign uterine bleeding; with special reference to the use of ergot.
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D002317:Cardiovascular Agents; D003475:Curettage; D004874:Ergonovine; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008595:Menorrhagia / Q000628:therapy*; D008796:Metrorrhagia / Q000628:therapy*; D018218:Neoplasms, Fibrous Tissue; D010120:Oxytocics; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D010120:Oxytocics; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D004874:Ergonovine
ERGOT ALKALOIDS/therapeutic use; MENORRHAGIA AND METRORRHAGIA/therapy
Med Clin North Am. 1950 Sep;34(5):1551-65
14775341
West J Surg Obstet Gynecol. 1952 Feb;60(2):49-52
14901756